Gene · 4940
Papers2,054
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,054
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Caffeic Acid Phenethyl Ester (CAPE): Biosynthesis, Derivatives and Formulations with Neuroprotective Activities. | Antioxidants (Basel) | 2023 | 37627495 | PubTator, text mining | PubMed |
| Transcriptional profiling of immune responses in NHPs after low-dose, VSV-based vaccination against Marburg virus. | Emerg Microbes Infect | 2023 | 37616377 | PubTator, text mining | PubMed |
| TRIM5 Promotes Systemic Lupus Erythematosus Through CD4(+) T Cells and Macrophage. | Int J Gen Med | 2023 | 37614552 | PubTator, text mining | PubMed |
| Exploring the shared molecular mechanisms between systemic lupus erythematosus and primary Sjögren's syndrome based on integrated bioinformatics and single-cell RNA-seq analysis. | Front Immunol | 2023 | 37614232 | PubTator, text mining | PubMed |
| SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice. | Proc Natl Acad Sci U S A | 2023 | 37607224 | PubTator, text mining | PubMed |
| Rare genetic variants involved in multisystem inflammatory syndrome in children: a multicenter Brazilian cohort study. | Front Cell Infect Microbiol | 2023 | 37588055 | PubTator, text mining | PubMed |
| Mechanistic Study on the Degradation of Hydrolysable Core-Crosslinked Polymeric Micelles. | Langmuir | 2023 | 37581242 | PubTator, text mining | PubMed |
| The Transcriptome Landscape of the In Vitro Human Airway Epithelium Response to SARS-CoV-2. | Int J Mol Sci | 2023 | 37569398 | PubTator, text mining | PubMed |
| Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability. | Int J Mol Sci | 2023 | 37569262 | PubTator, text mining | PubMed |
| COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists' scope of practice. | Res Social Adm Pharm | 2023 | 37567834 | PubTator, text mining | PubMed |
| High expression of IL6 and decrease in immune cells in COVID-19 patients combined with myocardial injury. | Front Immunol | 2023 | 37564653 | PubTator, text mining | PubMed |
| Extravillous trophoblast cell lineage development is associated with active remodeling of the chromatin landscape. | Nat Commun | 2023 | 37563143 | PubTator, text mining | PubMed |
| Dissecting human population variation in single-cell responses to SARS-CoV-2. | Nature | 2023 | 37558883 | PubTator, text mining | PubMed |
| Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. | Nat Commun | 2023 | 37550294 | PubTator, text mining | PubMed |
| Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways. | Commun Biol | 2023 | 37543704 | PubTator, text mining | PubMed |
| Development of a human iPSC-derived placental barrier-on-chip model. | iScience | 2023 | 37534160 | PubTator, text mining | PubMed |
| The prospective outcome of the monkeypox outbreak in 2022 and characterization of monkeypox disease immunobiology. | Front Cell Infect Microbiol | 2023 | 37533932 | PubTator, text mining | PubMed |
| The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle. | PLoS Pathog | 2023 | 37523412 | PubTator, text mining | PubMed |
| Quantitative multiorgan proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation. | EMBO Mol Med | 2023 | 37519267 | PubTator, text mining | PubMed |
| Infection Meets Inflammation: N6-Methyladenosine, an Internal Messenger RNA Modification as a Tool for Pharmacological Regulation of Host-Pathogen Interactions. | Biomolecules | 2023 | 37509095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4940/papers?page=11